Mark Fredric Cotton

32PUBLICATIONS
117CO-AUTHORS
Disease surveillanceNanotoxicology, health and safetyMajor global burdens of diseaseModels of care and place of birthNeurogenetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (32)

|Jun 03, 2026
Dolutegravir as First- or Second-line Treatment for Children With HIV: 240-Week Follow-up of the ODYSSEY Randomized Trial.

|May 06, 2026
VRC01 with antiretroviral initiation in infants is well tolerated, and higher concentrations associate with greater HIV-1 DNA declines.

|Apr 12, 2026
Predictors of Treatment Failure in Children With HIV Starting First-line Antiretroviral Therapy in the ODYSSEY Trial.

James Wyncoll, Rujirek Kamolrattana, Moherndran Archary

|Nov 07, 2025
Postnatal HIV vertical transmission and the impact of infant feeding choice in the ART era.

Victoria Ndarukwa, Mark Cotton, Moleen Zunza

|Jul 30, 2025
Differential HIV-1 Proviral Defects in Children vs. Adults on Antiretroviral Therapy.

Jenna M Hasson, Mary Grace Katusiime, Adam A Capoferri

|Aug 02, 2024
Lamivudine dosing for preterm infants exposed to HIV: a population pharmacokinetic modelling and simulation study.

Adrie Bekker, Edmund V Capparelli, Mark Mirochnick

Pageof 6

Frequent Collaborators

5 joint publications

Barbara Laughton

5 joint publications

Shaun L Barnabas

4 joint publications

Lisa J Frigati

3 joint publications

Gert van Zyl